A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy

Clinical trial NCT07091305 · RECRUITING

Trial details

NCT number: NCT07091305
Sponsor: Shanghai Chest Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Limited-stage Small Cell Lung Cancer (LS-SCLC)Chemoradiotherapy Induction Therapy Consolidation Immunotherapy

Start date: 2025-10-23
Primary completion: 2027-08-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.